BTIG Reiterates Buy on AtriCure, Maintains $54 Price Target

AtriCure, Inc. -0.96%

AtriCure, Inc.

ATRC

30.02

-0.96%

BTIG analyst Marie Thibault reiterates AtriCure (NASDAQ: ATRC) with a Buy and maintains $54 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via